Milder Donald B's Form 4 filing
Inari Medical, Inc. (NARI) · filed Aug 17, 2022
- Accession no.
- 0001127602-22-021204
- Filed
- Aug 17, 2022
- Trade date
- Aug 12-15, 2022
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $565.5K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Milder Donald BCIK 0001279660 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2022 | Common Stock | GGiftDisposed | −210,000 | $0.00 | $0 | 3,213,614 | Indirect | |
| Aug 15, 2022 | Common Stock | SSaleDisposed | −5,500 | $80.56F3 | −$443,080 | 3,208,114 | Indirect | |
| Aug 15, 2022 | Common Stock | SSaleDisposed | −1,200 | $81.41F4 | −$97,692 | 3,206,914 | Indirect | |
| Aug 15, 2022 | Common Stock | SSaleDisposed | −300 | $82.40F5 | −$24,720 | 3,206,614 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $80.08 to $81.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $81.11 to $81.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $82.34 to $82.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.